Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

The Non-pharmaceutical Application Term Sheet Provides That Enveric Could Be Eligible To Receive Future Development And Sales Milestone Payments, Of Up To Approximately $21M And With Royalty Rates Ranging From 0.25% Up To 7%

Author: Benzinga Newsdesk | March 19, 2024 07:09am

Posted In: ENVB